Clobazam Tablet
Product Images NDC 16714-887

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 16714-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clobcontlabel10mg

Clobcontlabel10mg
Clobazam Tablets, NDC 16714-887-01, are available in a package of 100 tablets, and each tablet contains 10 mg of clobazam. Pharmacists are instructed to dispense the medication guide provided separately to each patient. The usual dosage is described in the package insert for full prescribing information. The tablets should be stored at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature] and dispensed in a USP tight container. Medication guides are available at www.northstamxlic.com/products or by calling 1-800-206-7821. These tablets are manufactured for Northstar Rx LLC, Memphis, TN 38141, by Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India. However, it should be noted that the text is missing some characters and words, making it difficult to interpret in some parts.*
FDA Label Image

Clobcontlabel20mg

Clobcontlabel20mg
Clobazam Tablets containing 20mg of clobazam are sold in bottles of 100 tablets. The package insert should be reviewed for full information on recommended dosage. Storage requirements include a temperature between 20°C and 25°C, in addition to a USP tight container for dispensing. Manufacturing is conducted by Hetero Labs Limited in Hyderabad, India, and Northstar Rx LLC distributes the products. The Medication Guide provided for each patient and can be accessed on the Northstar website.*
FDA Label Image

Clobfig1

FDA Label Image

Clobfig2

Clobfig2
This seems to be a chart or table showing the proportion of patients, classified by their response to different treatments, in terms of percentage. The treatments may involve a placebo, low, medium, or high doses of Clobazam, and the patients' responses may be worse, or an improvement in the weekly drop seizure frequency from baseline, expressed as a percentage. It does not provide enough context for further interpretation or analysis.*
FDA Label Image

Clobtabstructure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.